Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Relan, Vandana ^a,b   Morrison, Leanne ^b   Parsonson, Kylie ^a,b   Clarke, Belinda E ^b   Duhig, Edwina E ^b   Windsor, Morgan N ^b   Matar, Kevin S ^b   Naidoo, Rishendran ^b   Passmore, Linda ^a,b   McCaul, Elizabeth ^a,b   Courtney, Deborah ^a,b   Yang, Ian A ^a,b   Fong, Kwun M ^a,b   Bowman, Rayleen V ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CYTOKERATIN 19;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CELL GROWTH; CELL SHAPE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CELL VIABILITY; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME 22; CHROMOSOME 8; CLINICAL ARTICLE; DNA FINGERPRINTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KARYOTYPE; KARYOTYPING; MALE; MICROVILLUS; MONOSOMY; PHENOTYPE; PLEURA MESOTHELIOMA; POLYPLOIDY; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STELLATE CELL; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; MESOTHELIOMA; MIDDLE AGED; PHENOTYPE; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84875026055     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058132     Document Type: Article

References (39)

1. Safe work Australia (2009) Mesothelioma in Australia- INCIDENCE 1982 TO 2005, DEATHS 1997 TO 2006; Mesothelioma in Australia,.
2. Bianchi CBT (2007) Malignant mesothelioma: global incidence and relationship with asbestos. Industrial Health 45 379-387.
3. Bowman RRV, Hughes B, (2011) Medical management of mesothelioma. Australian Prescriber 34 5: 144-147.
4. Sato G (2008) Tissue culture: the unrealized potential. Cytotechnology 57.
5. Sato GH, Sato JD, Okamoto T, McKeehan WL, Barnes DW, (2010) Tissue culture: the unlimited potential. In Vitro Cell Dev Biol Anim 46: 590-594.
6. Xiao GH GR, Shetler J, Skele K, Altomare DA, Pestell RG, et al. (2005) The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol 25: 2384-2394.
7. Ivanov SV IA, Goparaju CM, Chen Y, Beck A, Pass HI, (2009) Tumorigenic properties of alternative osteopontin isoforms in mesothelioma. Biochem Biophys Res Commun 382: 514-518.
8. Veldwijk MR, Jauch A, Laufs S, Zeller WJ, Wenz F, et al. (2008) Characterization of human mesothelioma cell lines as tumor models for suicide gene therapy. Onkologie 31: 91-96.
9. Manning LS, Whitaker D, Murch AR, Garlepp MJ, Davis MR, et al. (1991) Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions. Int J Cancer 47: 285-290.
10. Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, et al. (2006) Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci 97: 387-394.
11. Philippeaux MM, Dahoun S, Barnet M, Robert JH, Mauël J, et al. (2004) Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis. Histochem Cell Biol 122: 249-260.
12. Roth V (2006) http://www.doubling-time.com/compute.php.Accessed 2012, Feb.
13. Ori S, Chang JT, Andrechek ER, Matsumura N, Baba T, et al. (2009) Anchorage-independent cell growth signature identifies tumorswith metastatic potential Oncogene. 28: 2796-2805.
14. Dong Woo Kang S-HL, Jeong Whan Yoon, et al. (2010) Phospholipase D1 Drives a Positive Feedback Loop to Reinforce the Wnt/b-Catenin/TCF Signaling Axis. Cancer Res 70: 4233-4242.
15. Suster S, Moran C, (2005) Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile. Expert Rev Mol Diagn 5: 715-723.
16. Schaffer WI, (1990) Terminology associated with cell, tissue, and organ culture, molecular biology, and molecular genetics. Tissue Culture Association Terminology Committee. In Vitro Cell Dev Biol 26: 97-101.
17. Gazdar AF, Carney DN, Guccion JG, Baylin SB (1981) Small cell carcinoma of the lung: Cellular origin and relationship to other pulmonary tumors,. In Greco, F A, Oldham, R K and Bunn,P A (eds), Small cell carcinoma of the lung, Grune & Stratton, New York,: 145-175.
18. Pass HI SE, Oie H, Tsokos MG, Abati AD, Fetsch PA, et al.(1995) Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 59.
19. Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L, Klockars M, Jantunen K, et al. (1990) Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 11: 673-681.
20. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
21. Freedman VH, Shin SI, (1974) Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359.
22. Marchevsky AM, (2008) Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med 132: 397-401.
23. Herrick SE, Mutsaers SE, (2004) Mesothelial progenitor cells and their potential in tissue engineering. The International Journal of Biochemistry & Cell Biology 36: 621-642.
24. Hiyama J, Marukawa M, Shiota Y, Ono T, Imai S, et al. (1998) Two familial mesothelioma cases with high concentrations of soluble cytokeratin 19 fragment in pleural fluid. Intern Med 37.
25. Suzuki H, Hirashima T, Kobayashi M, Sasada S, Okamoto N, et al. (2010) Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesothelioma. Anticancer Res 30: 4343-4346.
26. Orengo AM, Spoletini L, Procopio A, Favoni RE, De Cupis A, et al. (1999) Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. Eur Respir J 13: 527-534.
27. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, et al. (1997) Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 3: 908-912.
28. Sandberg.A.A (1983) A chromosomal hypothesis of oncogenesis. Cancer Genet Cytogenet 8: 277-285.
29. Tiainen M, Tammilehto L, Mattson K, Knuutila S, (1988) Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet Cytogenet 33: 251.
30. Björkqvist AM, Tammilehto L, Anttila S, Mattson K, Knuutila S, (1997) Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 75: 523-527.
31. Neragi-Miandoab S, Sugarbaker DJ, (2009) Chromosomal deletion in patients with malignant pleural mesothelioma. Interact CardioVasc Thorac Surg 9: 42-44.
32. Pylkkanen L SM, Ollikainen T, Mattson K, Nordling S, Carpen O, et al. (2002) Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region. Oncol Rep 9: 955-959.
33. UKCCCR (2000) Guidelines for the Use of Cell Lines in Cancer Research. British Journal of Cancer 82: 1495-1509.
34. Krismann M, Müller KM, Jaworska M, Johnen G, (2004) Pathological anatomy and molecular pathology. Lung Cancer 45: 29-33.
35. Lindholm PM, Salmenkivi K, Vauhkonen H, Nicholson AG, Anttila S, et al. (2007) Gene copy number analysis in malignant pleuralmesothelioma using oligonucleotide array CGH. Cytogenet Genome Res 119: 46-52.
36. Tiainen M, Tammilehto L, Rautonen J, Tuomi T, Mattson K, et al. (1989) Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br J Cancer 60: 618-626.
37. Knudson A, (1995) Asbestos and mesothelioma: Genetic lessons from a tragedy. Proc Natl Acad Sci 92: 10819-10820.
38. Wenger SL, Sargent LM, Bamezai R, Bairwa N, Grant SG, (2004) Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization. Biosci Rep 24: 631-639.
39. Zanazzi C, Hersmus R, Veltman IM, Gillis AJ, van Drunen E, et al. (2007) Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines. Genes Chromosomes Cancer 46: 895-908.